Comparison of short-term adverse reactions of small molecule inhibitors and biologics in the treatment of palmoplantar psoriasis and palmoplantar pustulosis: A systematic review and network Meta-analysis.

Humira (adalimumab) - AbbVie

Tremfya (guselkumab) - J&J

Skyrizi (risankizumab-rzaa) - AbbVie, Boehringer Ingelheim

Siliq (brodalumab) - Bausch Health

http://www.ncbi.nlm.nih.gov/pubmed/42727366

Chanxiu Li; Chenxin Li; Kaige Huang; Linxian Li; Peihan Zhang; Pingping Yang; Shengyi Lei; Yanran Yang; Yijin Zhao; Zhanxue Sun

Sep 12, 2026